These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31071124)

  • 1. Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    Ristić M; Milošević V; Medić S; Djekić Malbaša J; Rajčević S; Boban J; Petrović V
    PLoS One; 2019; 14(5):e0216219. PubMed ID: 31071124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.
    Patić A; Štrbac M; Petrović V; Milošević V; Ristić M; Hrnjaković Cvjetković I; Medić S
    PLoS One; 2020; 15(1):e0227413. PubMed ID: 31929584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C; Pachón I; de Ory F
    Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.
    Izadi S; Zahraei SM; Mokhtari-Azad T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1412-1416. PubMed ID: 29420120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
    Doshi S; Khetsuriani N; Zakhashvili K; Baidoshvili L; Imnadze P; Uzicanin A
    Int J Epidemiol; 2009 Feb; 38(1):182-91. PubMed ID: 19074954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of mumps in an epidemic period in Medellín, Colombia.
    Santacruz-Sanmartín E; Hincapié-Palacio D; Ospina MC; Perez-Toro O; Bernal-Restrepo LM; Buitrago-Giraldo S; Lenis-Ballesteros V; Díaz FJ
    Vaccine; 2015 Oct; 33(42):5606-5612. PubMed ID: 26363380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
    Johnson H; Hillary IB; McQuoid G; Gilmer BA
    Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological survey of measles immunity in the Czech Republic, 2013.
    Tomášková H; Zelená H; Kloudová A; Tomášek I
    Cent Eur J Public Health; 2018 Mar; 26(1):22-27. PubMed ID: 29684293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward measles and rubella elimination in Egypt.
    El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
    J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
    Nogareda F; Gunregjav N; Sarankhuu A; Munkhbat E; Ichinnorov E; Nymadawa P; Wannemuehler K; Mulders MN; Hagan J; Patel MK
    Vaccine; 2020 May; 38(26):4200-4208. PubMed ID: 32381479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program.
    Ngaovithunvong V; Wanlapakorn N; Tesapirat L; Suratannon N; Poovorawan Y
    J Infect Dev Ctries; 2016 Aug; 10(7):735-40. PubMed ID: 27482805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.